172 related articles for article (PubMed ID: 21165571)
21. TGFB1 promoter polymorphism C-509T and pathophysiology of asthma.
Ueda T; Niimi A; Matsumoto H; Takemura M; Yamaguchi M; Matsuoka H; Jinnai M; Chin K; Minakuchi M; Cheng L; Shirakawa T; Mishima M
J Allergy Clin Immunol; 2008 Mar; 121(3):659-64. PubMed ID: 18036644
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
[TBL] [Abstract][Full Text] [Related]
23. SNPs in LncRNA genes are associated with non-small cell lung cancer in a Chinese population.
Wang R; Feng N; Wang Y; Gao S; Zhang F; Qian Y; Gao M; Yu H; Zhou B; Qian B
J Clin Lab Anal; 2019 May; 33(4):e22858. PubMed ID: 30980423
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.
Yang Y; Fei F; Song Y; Li X; Zhang Z; Fei Z; Su H; Wan S
Cancer Sci; 2014 Jan; 105(1):89-96. PubMed ID: 24304228
[TBL] [Abstract][Full Text] [Related]
25. Association of transforming growth factor-beta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer.
Zhang P; Di JZ; Zhu ZZ; Wu HM; Wang Y; Zhu G; Zheng Q; Hou L
Jpn J Clin Oncol; 2008 Dec; 38(12):861-6. PubMed ID: 18936038
[TBL] [Abstract][Full Text] [Related]
26. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.
Wang Y; Peng X; Zhu L; Hu L; Song Y
Oncotarget; 2016 May; 7(18):26436-43. PubMed ID: 27050379
[TBL] [Abstract][Full Text] [Related]
29. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
[TBL] [Abstract][Full Text] [Related]
30. The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.
Geng N; Su J; Liu Z; Ding C; Xie S; Hu W
Technol Cancer Res Treat; 2021; 20():15330338211019433. PubMed ID: 34060368
[TBL] [Abstract][Full Text] [Related]
31. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
32. Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.
Liu HF; Liu JS; Deng JH; Wu RR
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081275
[TBL] [Abstract][Full Text] [Related]
33. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.
Liu Y; Bi Y; Lin J; Cao L; He B; Zhang Z; Cui Y; Zhang X
Tumour Biol; 2015 Mar; 36(3):1955-62. PubMed ID: 25394898
[TBL] [Abstract][Full Text] [Related]
34. Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer.
Singh H; Jain M; Mittal B
Oncol Res; 2009; 18(1):41-5. PubMed ID: 19911703
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt.
Kamal H; Hussein G; Hassoba H; Mosaad N; Gad A; Ismail M
Acta Cardiol; 2010 Apr; 65(2):177-83. PubMed ID: 20458825
[TBL] [Abstract][Full Text] [Related]
37. Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study.
Wang WP; Bian HB; Wang XZ; Liu L; Wei D
Medicine (Baltimore); 2021 May; 100(19):e25762. PubMed ID: 34106605
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population.
Xu P; Liu L; Wang J; Zhang K; Hong X; Deng Q; Xiang J; Zhang X; He M; Wu T; Guo H
PLoS One; 2013; 8(8):e72197. PubMed ID: 23977251
[TBL] [Abstract][Full Text] [Related]
39. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
40. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
